Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Submitted by
admin
on October 17, 2013 - 8:24am
Source:
Motley Fool
News Tags:
Parkinson's Disease
pimavanserin
Acadia
Duodopa
AbbVie
LCIG
AFQ056
Novartis
Headline:
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Do Not Allow Advertisers to Use My Personal information
